Immix Common Stock vs Total Liab Analysis
| IMMX Stock | USD 2.52 0.05 2.02% |
Immix Biopharma financial indicator trend analysis is infinitely more than just investigating Immix Biopharma recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Immix Biopharma is a good investment. Please check the relationship between Immix Biopharma Common Stock and its Total Liab accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Immix Biopharma. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population. For more information on how to buy Immix Stock please use our How to Invest in Immix Biopharma guide.
Common Stock vs Total Liab
Common Stock vs Total Liab Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Immix Biopharma Common Stock account and Total Liab. At this time, the significance of the direction appears to have pay attention.
The correlation between Immix Biopharma's Common Stock and Total Liab is -0.72. Overlapping area represents the amount of variation of Common Stock that can explain the historical movement of Total Liab in the same time period over historical financial statements of Immix Biopharma, assuming nothing else is changed. The correlation between historical values of Immix Biopharma's Common Stock and Total Liab is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Common Stock of Immix Biopharma are associated (or correlated) with its Total Liab. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Liab has no effect on the direction of Common Stock i.e., Immix Biopharma's Common Stock and Total Liab go up and down completely randomly.
Correlation Coefficient | -0.72 |
| Relationship Direction | Negative |
| Relationship Strength | Weak |
Common Stock
Total Liab
The total amount of all liabilities that a company has, including both short-term and long-term liabilities.Most indicators from Immix Biopharma's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Immix Biopharma current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Immix Biopharma. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population. For more information on how to buy Immix Stock please use our How to Invest in Immix Biopharma guide.At this time, Immix Biopharma's Selling General Administrative is fairly stable compared to the past year. Enterprise Value is likely to rise to about 107.6 M in 2024, whereas Tax Provision is likely to drop slightly above 12.5 K in 2024.
| 2021 | 2022 | 2023 | 2024 (projected) | Total Operating Expenses | 1.4M | 8.2M | 16.1M | 16.9M | Cost Of Revenue | 2.5K | 2.1K | 5.5K | 3.0K |
Immix Biopharma fundamental ratios Correlations
Click cells to compare fundamentals
Immix Biopharma Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Immix Biopharma offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Immix Biopharma's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Immix Biopharma Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Immix Biopharma Stock:Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Immix Biopharma. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population. For more information on how to buy Immix Stock please use our How to Invest in Immix Biopharma guide.You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Complementary Tools for Immix Stock analysis
When running Immix Biopharma's price analysis, check to measure Immix Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immix Biopharma is operating at the current time. Most of Immix Biopharma's value examination focuses on studying past and present price action to predict the probability of Immix Biopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Immix Biopharma's price. Additionally, you may evaluate how the addition of Immix Biopharma to your portfolios can decrease your overall portfolio volatility.
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios |
Is Immix Biopharma's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Immix Biopharma. If investors know Immix will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Immix Biopharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.89) | Return On Assets (0.58) | Return On Equity (1.06) |
The market value of Immix Biopharma is measured differently than its book value, which is the value of Immix that is recorded on the company's balance sheet. Investors also form their own opinion of Immix Biopharma's value that differs from its market value or its book value, called intrinsic value, which is Immix Biopharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Immix Biopharma's market value can be influenced by many factors that don't directly affect Immix Biopharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Immix Biopharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Immix Biopharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Immix Biopharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.